AQR CAPITAL MANAGEMENT LLC

Position in SLDB — Solid Biosciences Inc.

CIK 1167557 Greenwich, CT

Position in SLDB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,369,477

+$278,384 QoQ

Shares Held

137,085

-9.5% QoQ

Ownership

0.128%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#53

of 155 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. SLDB ranks #140 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,369,477	137,085	-9.5%	Shares	Other	2026-08-14
2026-03-31	$1,091,093	151,541	+14.8%	Shares	Defined	2026-05-15
2025-12-31	$744,234	131,957	+0.7%	Shares	Other	2026-02-17
2025-09-30	$808,619	131,057	+0.7%	Shares	Defined	2025-11-14
2025-06-30	$633,506	130,084	+15.0%	Shares	Other	2025-08-14
2025-03-31	$418,463	113,099	+198.1%	Shares	Other	2025-05-15
2024-09-30	$264,412	37,936	-81.9%	Shares	Other	2024-11-14
2022-06-30	$129,247	209,818	-43.0%	Shares	Defined	2022-08-15
2022-03-31	$441,517	367,931	+549.0%	Shares	Defined	2022-05-16
2021-12-31	$99,209	56,691	-52.4%	Shares	Defined	2022-02-14
2021-09-30	$284,641	119,097	-46.0%	Shares	Defined	2021-11-15
2021-06-30	$807,480	220,623	+37.2%	Shares	Defined	2021-08-16
2021-03-31	$889,494	160,849	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.